ASN
BIOR

Advisory Services Network’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Advisory Services Network’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1
Closed -$1K – 3195
2020
Q4 		$1K Buy
+1
New +$1.47K ﹤0.01% 3233

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's BIOR Position: Q1 2021 in Review

Advisory Services Network sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.

Advisory Services Network first reported a position in BIOR in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 47 funds tracked by Wall St. Rank hold BIOR as of Q1 2021.

  • Advisory Services Network reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 1 Biora Therapeutics, Inc. Common Stock share in Q1 2021, an estimated $1K.
  • Advisory Services Network first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Advisory Services Network's Biora Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.